首页> 外文期刊>Clinical Genetics: An International Journal of Genetics in Medicine >MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome
【24h】

MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome

机译:Kabuki综合征患者的MLL2镶嵌突变和基因内缺失重复

获取原文
获取原文并翻译 | 示例
           

摘要

Kabuki syndrome (KS) is a rare multi-system disorder that can result in a variety of congenital malformations, typical dysmorphism and variable learning disability. It is caused by MLL2 point mutations in the majority of the cases and, rarely by deletions involving KDM6A. Nearly one third of cases remain unsolved. Here, we expand the known genetic basis of KS by presenting five typical patients with the condition, all of whom have novel MLL2 mutation types- two patients with mosaic small deletions, one with a mosaic whole-gene deletion, one with a multi-exon deletion and one with an intragenic multi-exon duplication. We recommend MLL2 dosage studies for all patients with typical KS, where traditional Sanger sequencing fails to identify mutations. The prevalence of such MLL2 mutations in KS may be comparable with deletions involving KDM6A. These findings may be helpful in understanding the mutational mechanism of MLL2 and the disease mechanism of KS.
机译:歌舞uki综合征(KS)是一种罕见的多系统疾病,可导致多种先天性畸形,典型的畸形和可变性学习障碍。在大多数情况下,它是由MLL2点突变引起的,很少是由涉及KDM6A的缺失引起的。仍有近三分之一的案件尚未解决。在这里,我们通过介绍五位典型的患者,这些患者均患有新的MLL2突变类型,来扩展KS的已知遗传基础-两名患者有镶嵌小缺失,一名患者有镶嵌全基因缺失,一名患有多外显子删除和一个与基因内多外显子重复。我们建议对所有传统KS测序无法识别突变的典型KS患者进行MLL2剂量研究。 KS中此类MLL2突变的患病率可与涉及KDM6A的缺失相媲美。这些发现可能有助于理解MLL2的突变机制和KS的发病机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号